Search for: "GlaxoSmithKline, LLC "
Results 101 - 120
of 164
Sorted by Relevance
|
Sort by Date
1 Apr 2010, 3:04 am
MDCO launches another lawsuit against the PTO over Angiomax PTE (FDA Law Blog) Arzerra (Ofatumumab) – US: Biogen files patent infringement suit in S D California against Glaxosmithkline based on manufacture and sale of Arzerra (Patent Docs) Arzerra (Ofatumumab) – US: Genetech files counterclaims in declaratory judgment suit brought by GlaxoSmithKline (Patent Docs) Astelin (Azelastine) – US: District Court New Jersey: Patent infringement complaint following Para IV… [read post]
5 Aug 2021, 12:12 pm
GlaxoSmithKline LLC v. [read post]
11 May 2023, 1:16 pm
GlaxoSmithKline LLC. [read post]
10 Jun 2010, 3:58 am
LLC et al. v. [read post]
12 Nov 2010, 4:19 am
I couldn't help reflecting upon that when I saw what Corporate Counsel reported Wednesday: Federal prosecutors on Tuesday indicted (pdf) Lauren Stevens, the former associate general counsel of GlaxoSmithKline LLC, on charges of obstruction and making false statements about off-label uses of a drug. ... [read post]
1 Oct 2013, 7:25 am
GlaxoSmithKline LLC, 2013 WL 3993455, at *1-2 (E.D. [read post]
29 Jul 2022, 6:11 pm
GlaxoSmithKline, LLC 22-37Issue: Whether a generic drug manufacturer’s FDA-approved label that carves out all of the language the brand manufacturer has identified as covering its patented uses can be held liable on a theory that its label still intentionally encourages infringement of those carved-out uses. [read post]
29 Jul 2024, 4:52 am
We Help Whistleblowers Expose Fraud The Whistleblower Law Collaborative LLC helps whistleblowers expose government fraud. [read post]
19 Sep 2018, 9:55 am
ERSP Curtails Certain Purple Innovation, LLC’s Claims Promoting Its Purple Mattresses The Electronic Retailing Self-Regulation Program (“ERSP”) found that Purple Innovation, LLC, could support certain innovation claims for its Purple Mattresses, but recommended the marketer modify or discontinue other claims. [read post]
18 Sep 2016, 6:03 pm
(cross-petition asks for recourse on failure to dance) Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
8 Feb 2017, 3:09 am
Apple Inc., No. 16-651 Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
16 Jan 2017, 5:44 pm
Apple Inc., No. 16-651 Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
22 Dec 2022, 7:59 am
GlaxoSmithKline LLC, No. 22-37, has a good chance of being heard by the Court, although it may be better for Congress to work to resolve the pending questions. [read post]
11 Jul 2012, 3:04 am
© 2012 Simple Justice NY LLC. [read post]
30 May 2019, 6:02 am
GlaxoSmith Kline LLC that federal law prevented GlaxoSmithKline from adding a suicide warning label to the drug. [read post]
14 Nov 2016, 9:16 am
(cross-petition asks for recourse on failure to dance) Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
14 Jan 2018, 1:37 pm
Grp., LLC, No.8:10CV187, 2011 WL 5976264, at *4 (D. [read post]
14 Jan 2013, 7:30 am
By Guest Columnist: Donna Boehme Principal at Compliance Strategists LLC and editor of the weekly CS Newsflash (and former chief compliance and ethics officer at two leading multinationals). [read post]
28 Sep 2016, 8:39 am
(cross-petition asks for recourse on failure to dance) Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
13 Oct 2016, 6:50 am
(cross-petition asks for recourse on failure to dance) Antitrust Reverse Payments: GlaxoSmithKline, et al. v. [read post]
